Last reviewed · How we verify

NCT03961802: RESYSTE

Early and Systematic Shoulder Rehabilitation Following Cervical Lymph Node Dissection

Completed NA Last updated 24 January 2024
What this trial tests

NA trial testing sessions of shoulder rehabilitation in Rehabilitation in 120 participants. Completed in 16 November 2023.

Timeline
2 July 2019
Primary endpoint
16 November 2023
16 November 2023

Quick facts

Lead sponsorNantes University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment120
Start date2 July 2019
Primary completion16 November 2023
Estimated completion16 November 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Nantes University Hospital

Who can join

18 and older, any sex, with Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, monocentric, controlled, randomized study of systematic early shoulder rehabilitation following cervical lymph node dissection for the prevention and treatment of shoulder dysfunction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Rehabilitation

Currently open trials in the same condition.

Other Nantes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03961802.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing